Jiangzhong Pharmaceutical Company Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Jiangzhong Pharmaceutical Company Limited with three other
companies in this sector in China:
Shandong Shanda Wit Science and Technology Co Ltd
sales of 1.54 billion Chinese Renmimbi [US$228.68 million]
of which 57%
Guilin Sanjin Pharmaceutical Co Ltd
(1.53 billion Chinese Renmimbi [US$225.93 million]
of which 94%
was Proprietary Chinese medicine), and
Shanghai Shenqi Pharmaceutical Investment Management CoLtd
(1.60 billion Chinese Renmimbi [US$236.69 million]
of which 83%
During the year ended December of 2016, sales at
Jiangzhong Pharmaceutical Company Limited were 1.56 billion Chinese Renmimbi (US$231.30 million).
decrease of 39.9%
versus 2015, when the company's sales were 2.60 billion Chinese Renmimbi.
Contributing to the drop in overall sales was the 12.2% decline
in Medical Industry, from 1.77 billion Chinese Renmimbi to 1.56 billion Chinese Renmimbi.
However, these declines were partially offset by the increase in sales of
Wine Industry (up 752.1% to 2.62 million Chinese Renmimbi)